Cargando…
A DOUBLE-BLIND, PLACEBO-CONTROLLED EVALUATION OF THE ANXIOLYTIC EFFICACY FF AN ETHANOLIC EXTRACT OF WITHANIA SOMNIFERA
A double-blind, placebo-controlled study was conducted to evaluate the efficacy an ethanolic extract of Aswagandha (Withania somnifera), in patients with ICD-10 anxiety disorders. The sample comprised 39 subjects, of whom 20 received the drug and 19 received placebo. The two groups were sociodemogra...
Autores principales: | Andrade, Chittaranjan, Aswath, Anitha, Chaturvedi, S.K., Srinivasa, M., Raguram, R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958355/ https://www.ncbi.nlm.nih.gov/pubmed/21407960 |
Ejemplares similares
-
A DOUBLE-BLIND, CONTROLLED EVALUATION OF THE EFFICACY AND ADVERSE EFFECT PROFILE OF SUSTAINED-RELEASE ALPRAZOLAM
por: Andrade, Chittaranjan, et al.
Publicado: (2000) -
Withania Coagulans and Somnifera
por: Verghese, M.
Publicado: (1885) -
Effects of Withania somnifera in patients of schizophrenia: A randomized, double blind, placebo controlled pilot trial study
por: Agnihotri, Akshay P., et al.
Publicado: (2013) -
Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study
por: Singh, Priyam, et al.
Publicado: (2022) -
An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study
por: Lopresti, Adrian L., et al.
Publicado: (2019)